The weekly litigation news digest is live. Subscribe now

IP Verse

Methods Of Treating Lung Cancer - EP2968254

The patent EP2968254 was granted to Abraxis Bioscience on Apr 22, 2020. The application was originally filed on Mar 10, 2014 under application number EP14776420A. The patent is currently recorded with a legal status of "Revoked".

EP2968254

ABRAXIS BIOSCIENCE
Application Number
EP14776420A
Filing Date
Mar 10, 2014
Status
Revoked
Jul 7, 2023
Publication Date
Apr 22, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
TEVA PHARMACEUTICALSJan 19, 2021D YOUNGADMISSIBLE

Patent Citations (11) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2006263434
DESCRIPTIONUS2007082838
DESCRIPTIONUS5916596
DESCRIPTIONUS6096331
DESCRIPTIONUS6506405
DESCRIPTIONUS6537579
DESCRIPTIONUS6749868
DESCRIPTIONUS7820788
DESCRIPTIONUS8034375
DESCRIPTIONWO2008137148
OPPOSITIONUS8143236

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents